's () Stephen O'Hara explains how the company managed to prove their commercial model with a solid foundation to begin 2021 in a strong position.
He sets out the agenda for 2021 which is to 'focus on the next generation of products'.
The company's key products, in which there are now 78 deals ongoing are weight management lines SlimBiome and SlimBiome Medical, LPLDL (cholesterol) and SweetBiotix (sweetener).
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE